Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
19.41
-0.04 (-0.23%)
At close: Sep 11, 2026, 4:00 PM EDT
19.00
-0.41 (-2.09%)
After-hours: Sep 11, 2026, 4:10 PM EDT
Surrozen Revenue
Surrozen had revenue of $5.00M in the quarter ending June 30, 2026, with 408.65% growth. This brings the company's revenue in the last twelve months to $11.51M, down -8.79% year-over-year. In the year 2025, Surrozen had annual revenue of $3.48M, down -67.37%.
Revenue (ttm)
$11.51M
Revenue Growth
-8.79%
P/S Ratio
19.41
Revenue / Employee
$261,614
Employees
44
Market Cap
228.08M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.48M | -7.18M | -67.37% |
| Dec 31, 2024 | 10.66M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 12.50M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Niagen Bioscience | 129.08M |
| Compugen | 74.00M |
| Cellectis | 63.82M |
| Invivyd | 58.37M |
| Adagene | 9.29M |
| Whitehawk Therapeutics | 7.15M |
SRZN News
- 1 day ago - Surrozen Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 3 days ago - Surrozen submits investigational new drug application for SZN-8141 - TheFly
- 3 days ago - Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema - GlobeNewsWire
- 7 days ago - Surrozen Slides: Corporate presentation - Filings
- 9 days ago - Surrozen to Present at Upcoming Healthcare Investor Conferences - GlobeNewsWire
- 22 days ago - Surrozen initiated with an Outperform at William Blair - TheFly
- 5 weeks ago - Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Surrozen Quarterly report: Q2 2026 - Filings